Prognostic value of microRNA-4521 in non-small cell lung cancer and its regulatory effect on tumor progression

Sun Butong; Cong Dan; Chen Kang; Bai Yuansong; Li Jun

doi:10.1515/med-2021-0312

Open Medicine (Aug 2021)

Prognostic value of microRNA-4521 in non-small cell lung cancer and its regulatory effect on tumor progression

Sun Butong,
Cong Dan,
Chen Kang,
Bai Yuansong,
Li Jun

Affiliations

Sun Butong: Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130031, China
Cong Dan: Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130031, China
Chen Kang: Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130031, China
Bai Yuansong: Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, No. 126 of Xiantai Street, Changchun, Jilin, 130031, China
Li Jun: Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, No. 126 of Xiantai Street, Changchun, Jilin, 130031, China

DOI: https://doi.org/10.1515/med-2021-0312
Journal volume & issue: Vol. 16, no. 1
pp. 1150 – 1159

Abstract

Read online

Non-small cell lung cancer (NSCLC) is a malignant tumor with the highest mortality rate in our country. It has been found in many studies that microRNA-4521 (miR-4521) is abnormally expressed and plays a role in clear cell renal cell carcinoma and other cancers.

Published in Open Medicine

ISSN: 2391-5463 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Medicine
Website: https://www.degruyter.com/journal/key/med/html

About the journal

Abstract

Keywords